Product Code: ETC069944 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The biosimilars market in Thailand has experienced significant growth in recent years, driven by increasing demand for cost-effective and accessible biologic drugs. Biosimilars are highly similar versions of reference biologics, offering comparable therapeutic outcomes and safety profiles at a lower cost. These products play a crucial role in expanding patient access to advanced therapies and reducing healthcare expenditure. The Thailand government`s efforts to promote biosimilar adoption, coupled with the rising prevalence of chronic diseases, have contributed to the market`s expansion. Biosimilar manufacturers in Thailand are actively engaged in research, development, and partnerships to strengthen their market presence.
The biosimilars market in Thailand has experienced significant growth in recent years, driven by increasing demand for cost-effective and accessible biologic drugs. Biosimilars are highly similar versions of reference biologics, offering comparable therapeutic outcomes and safety profiles at a lower cost. These products play a crucial role in expanding patient access to advanced therapies and reducing healthcare expenditure. The Thailand government`s efforts to promote biosimilar adoption, coupled with the rising prevalence of chronic diseases, have contributed to the market`s expansion. Biosimilar manufacturers in Thailand are actively engaged in research, development, and partnerships to strengthen their market presence.
While the biosimilars market presents significant opportunities, it also faces several challenges. One major hurdle is the complexity and cost of biosimilar development and manufacturing. Biosimilars require extensive analytical, preclinical, and clinical studies to demonstrate similarity to the reference product, making the development process time-consuming and resource-intensive. Additionally, concerns related to immunogenicity and interchangeability with the reference biologics require thorough evaluation and communication to gain the confidence of healthcare providers and patients. Moreover, intellectual property and legal considerations may pose barriers for biosimilar manufacturers, especially when navigating patent disputes with originator companies.
The Covid-19 pandemic has had a mixed impact on the biosimilars market in Thailand. While the immediate focus was on managing the pandemic, the demand for biosimilars remained resilient due to their cost-effective nature and the need to continue essential treatments. However, disruptions in healthcare services and supply chains during the pandemic did affect biosimilar distribution and uptake to some extent. The pandemic also highlighted the importance of a secure and sustainable supply of essential medicines, emphasizing the need for a robust and diversified biosimilars market in Thailand.
The biosimilars market in Thailand is supported by several key players, both local and multinational. Local companies such as BioNet-Asia Co., Ltd. and Siam Bioscience Co., Ltd. have been actively engaged in the development and manufacturing of biosimilars for the domestic and international markets. Additionally, multinational pharmaceutical companies like Pfizer Inc., Novartis AG, and Celltrion, Inc. have a significant presence in the Thailand biosimilars market, leveraging their global expertise and research capabilities. These key players engage in partnerships with healthcare institutions, government bodies, and international organizations to strengthen their biosimilars portfolio and enhance patient access to affordable and high-quality biologic therapies in Thailand.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Biosimilars Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Biosimilars Market Revenues & Volume, 2020 & 2027F |
3.3 Thailand Biosimilars Market - Industry Life Cycle |
3.4 Thailand Biosimilars Market - Porter's Five Forces |
3.5 Thailand Biosimilars Market Revenues & Volume Share, By Product, 2020 & 2027F |
3.6 Thailand Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2027F |
3.7 Thailand Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2027F |
4 Thailand Biosimilars Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Biosimilars Market Trends |
6 Thailand Biosimilars Market, By Types |
6.1 Thailand Biosimilars Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Thailand Biosimilars Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 Thailand Biosimilars Market Revenues & Volume, By Insulin, 2018 - 2027F |
6.1.4 Thailand Biosimilars Market Revenues & Volume, By Follitropin, 2018 - 2027F |
6.1.5 Thailand Biosimilars Market Revenues & Volume, By Calcitonin, 2018 - 2027F |
6.1.6 Thailand Biosimilars Market Revenues & Volume, By Glucagon, 2018 - 2027F |
6.1.7 Thailand Biosimilars Market Revenues & Volume, By Teriparatide, 2018 - 2027F |
6.1.8 Thailand Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 Thailand Biosimilars Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Thailand Biosimilars Market Revenues & Volume, By Oncology, 2018 - 2027F |
6.2.3 Thailand Biosimilars Market Revenues & Volume, By Offsite Treatment, 2018 - 2027F |
6.2.4 Thailand Biosimilars Market Revenues & Volume, By Chronic Disorders, 2018 - 2027F |
6.2.5 Thailand Biosimilars Market Revenues & Volume, By Blood Disorders, 2018 - 2027F |
6.2.6 Thailand Biosimilars Market Revenues & Volume, By Infectious Diseases, 2018 - 2027F |
6.2.7 Thailand Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F |
6.3 Thailand Biosimilars Market, By Manufacturing |
6.3.1 Overview and Analysis |
6.3.2 Thailand Biosimilars Market Revenues & Volume, By Outsourced, 2018 - 2027F |
6.3.3 Thailand Biosimilars Market Revenues & Volume, By In-house, 2018 - 2027F |
7 Thailand Biosimilars Market Import-Export Trade Statistics |
7.1 Thailand Biosimilars Market Export to Major Countries |
7.2 Thailand Biosimilars Market Imports from Major Countries |
8 Thailand Biosimilars Market Key Performance Indicators |
9 Thailand Biosimilars Market - Opportunity Assessment |
9.1 Thailand Biosimilars Market Opportunity Assessment, By Product, 2020 & 2027F |
9.2 Thailand Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2027F |
9.3 Thailand Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2027F |
10 Thailand Biosimilars Market - Competitive Landscape |
10.1 Thailand Biosimilars Market Revenue Share, By Companies, 2020 |
10.2 Thailand Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |